Tonix Pharmaceuticals Holding SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

4Nov. 12, 2026, 8 a.m. ETView on SEC.gov
10-QNov. 9, 2026, 8:25 a.m. ETView on SEC.gov
8-KNov. 9, 2026, 7:20 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedTonix Pharmaceuticals Q3 2026 Revenue of $17.2 Million Beats $16.3 Million Consensus, but GAAP EPS of -$2.89 Misses -$2.24 Estimate
8-KOct. 15, 2026, 7 a.m. ETView on SEC.gov
Results of operations and financial condition · Other events
8-KOct. 2, 2026, 5:20 p.m. ETView on SEC.gov
Other events
8-KSept. 22, 2026, 7:05 a.m. ETView on SEC.gov
Other events · Financial statements and exhibits
8-KSept. 8, 2026, 7:05 a.m. ETView on SEC.gov
Other events · Financial statements and exhibits
4Aug. 31, 2026, 8 a.m. ETView on SEC.gov
4Aug. 24, 2026, 8 a.m. ETView on SEC.gov
8-KAug. 18, 2026, 4 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Other events
SCHEDULE 13G/AAug. 14, 2026, 8:36 a.m. ETView on SEC.gov
SCHEDULE 13GAug. 13, 2026, 9:17 a.m. ETView on SEC.gov
10-QAug. 10, 2026, 8:09 a.m. ETView on SEC.gov
8-KAug. 10, 2026, 7:15 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
8-KAug. 3, 2026, 7:05 a.m. ETView on SEC.gov
Regulation FD disclosure · Other events · Financial statements and exhibits